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from Varian (Varian, Palo Alto, USA) integrates, for cranial 
lesions, the common Cone Beam Computed Tomography 
(CBCT) and kV-MV portal images to the Optical Surface 
Monitoring System (OSMS), a device able to detect real-time 
patient’s face movements in all 6 couch axes (vertical, 
longitudinal, lateral, rotation, pitch and roll). We have 
evaluated the OSMS imaging capability in checking the 
patient’s position and monitoring its motion. 
Materials and Methods: An home-made cranial phantom was 
developed to evaluate the OSMS accuracy in four different 
experiments: (i) comparison with CBCT in isocenter location; 
(ii) capability to recognize predefined shifts up to 2-3°/cm; 
(iii) evaluation at different couch angles; (iv) ability to 
properly reconstruct the surface when one camera is covered 
by the EDGE. 
Results: The OSMS system showed to be accurate for patient 
positioning respect to the CBCT imaging system with 
difference of 0.6±0.3 mm for linear vector displacement, 
with a maximum rotational inaccuracy of 0.3°. OSMS 
presented an accuracy of 0.3 mm for displacement up to 1 
cm and 1°, and 0.5 mm for larger displacements. Different 
couch angles induced a mean vector uncertainty <0.4 mm. 
Coverage of one camera produced an uncertainty <0.5 mm. 
Conclusions: In conclusion, OSMS could be considered 
suitable for SRS accuracy positioning and monitoring. 
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Purpose/Objective: The radiobiological characteristics of 
prostate cancer have been investigated and evidence 
suggests a low alpha/beta ratio. As a result, increased 
tumour cell kill should correlate with increased dose per 
fraction. Improved tumour control rates should be possible by 
delivering large doses/fraction without increasing normal 
tissue toxicity.  
Although in-vivo studies have supported this, the radiation 
delivery techniques reported have tended to use Cyberknife 
or other less sophisticated linear accelerator techniques.  
The objective of this study was to assess feasibility, safety 
and efficiency of delivering FFF volumetric arc therapy for 
prostate SABR using: fiducial markers for verification and 
MRI/CT fusion for delineation. 
Materials and Methods: Ethically approved safety and 
feasibility study including first 17 patients with low-
intermediate risk prostate cancer, PSA ≤ 20 ng/ml and a 
Gleason score ≤7. MRI/CT image fusion was used for target 
delineation. 
Patients planned using Varian Eclipse (v.10.0.42) 10X FFF (2 
arcs) and treated using Varian Truebeam STX to a dose of 
35Gy/5 fractions. Patients were treated on the planned 
delivery schedule of alternate days which resulted in an 
overall treatment period of 11 days. Cone-beam CT images 
were acquired pre and post treatment. Patients were 
assessed for acute and late gastro-intestinal (GI) and genito-
urinary (GU) toxicity before each treatment and at 4, 10 and 
18 weeks. Planning criteria was assessed ensuring it was a 
clinically feasible method of planning and beam on time was 
recorded to assess efficiency. 
Results:  
Feasibility: Clinically acceptable plans were achieved for 
100% of reported patients. (Table 1) 
Safety: No RTOG acute toxicity of grade > 3 was recorded for 
any of the 17 patients. 
Efficiency: Mean treatment time for a course of conventional 
radiotherapy 1814.48 seconds and for SABR 603.1 seconds. 
This demonstrates a significant reduction in BOT of 67% for 
study patients (p=<0.001). (Table 1) 
 
Conclusions: Following the assessment of the first 17 
patients, the research team is satisfied that all outcomes 
from this study are being met. Planning data has been 
achieved for all patients allowing treatment using the study 
method to proceed. Treatment has been tolerated well by 
patients with acute toxicity being within acceptable limits. A 
significant reduction in BOT has also demonstrated the study 
technique to be efficient.  
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Purpose/Objective: An important step in radiotherapy 
treatment delivery is the accuracy of patient positioning. In 
order to ensure the accuracy, stability and reproducibility of 
the HexaPODTM robotic table, we started doing, since its 
initial clinical use in March 2014, weekly setup verifications 
with a QUASARTM Penta-Guide phantom in combination with 
Elekta XVI CBCT. The objective is to verify if the couch, after 
applying known shifts in all directions, is able to reposition 
the phantom at the isocentre with high precision and very 
low and small deviations. Quality assurance (QA) of the XVI 
system alone is performed apart. 
3rd ESTRO Forum 2015                                                                                                                                         S917 
 
Materials and Methods: The test is performed with a cubic 
phantom (Penta-Guide) with air-filled spheres and dedicated 
to CBCT quality assurance. The HexaPODTM table is positioned 
in its zero location to allow maximum corrections in all 
directions. The Penta-Guide is located at the isocentre with 
the room lasers and we apply known displacements in all 
translational directions with the phantom off-centre cross 
hair (10 mm X, 14 mm Y and 12 mm Z). Positioning accuracy 
is tested by comparing a reference CBCT phantom image with 
the weekly CBCT by the grey scale auto match tools of Elekta 
XVI. The translational and rotational corrections determined 
by registration are then transferred to the iGuide system, the 
software that controls de HexaPODTM table, to apply the 
requested shifts to reposition the phantom. Translational and 
rotational position errors are recorded and analyzed. 
Results: From 25 images (which correspond to 75 
translational and 75 rotational displacement measurements), 
we have found that 97.3% of all translational errors in 
achieving the isocentre location are <=1 mm (96% in 
longitudinal and vertical directions and 100% in lateral 
direction). The average translational error is 0.47 mm 
longitudinal (0.20 – 1.40 mm), 0.45 mm lateral (0.00 – 1.00 
mm) and 0.34 mm vertical (0.00 – 1.10 mm). 92% of all 
rotational errors are <=0.3º (88% roll, 92% pitch and 96% 
yaw). The average rotational error is 0.15º roll (0.00º – 
0.40º), 0.17º pitch (0.00º – 0.40º) and 0.13º yaw (0.00º – 
0.50º). 
Conclusions: The HexaPODTM table can correct setup errors in 
all planes with a very high precision level. A QA procedure is 
necessary to detect errors in a system with a sub-millimetre 
and a sub-degree accuracy aim. This QA test assures that 
mean setup error do not exceed 0.5 mm in translational 
directions and is below 0.2º in rotational movements. If we 
find errors exceeding our action levels (2 mm in translational 
and 1º rotational), further investigations have to be done. 
Because its simplicity and the benefits that can report to 
patient setup, we are considering to implement this test in 
our clinical daily basis. 
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Purpose/Objective: to evaluate the efficacy of the Image 
Guided Radiotherapy (IGRT) with daily Megavoltage CT 
(MVCT) and acute toxicity in patients with nasopharynx 
cancer treated with HT. 
Materials and Methods: From January 2013 to May 2014, 13 
patients (pts), 9 females and 4 males, median age 64 years, 
with nasopharynx cancer (T2-T4a N2-N3), were treated and 
evaluate for acute toxicity, analyzing loss of weight, 
xerostomia, dysphagia, mucositis and dermatitis. Among 
them, 9 pts underwent platinum-based chemotherapy and 
concomitant radiotherapy and 4 pts exclusive radiotherapy, 3 
due to poor general condition and 1 for the elderly. Three 
differents planning target volume (PTVs) were defined: PTV1 
included nasopharynx (local disease and margin) to a total 
dose (DT) of 69.96 Gy in 33 fractions (frs) with a daily fr of 
2.12 Gy; PTV2 included lymph nodes high risk and we 
administered a DT of 59.4Gy in 33 frs at a daily fr of 1.8 Gy. 
PTV3 included lymph nodes low risk treated with a DT of 
54.12 Gy in 33 frs at a daily fr of 1.64 Gy. Acute toxicity was 
evaluated using a questionnaire NCI- CTCAE 4.0 modified by a 
subjective scale of values from 1 to 10 (1 at the worst result 
and 10 at the best) investigating different types of toxicity in 
particular: xerostomia, dysphagia for liquids and solids (L/S), 
dysgeusia. We evaluate also weight loss and, according to the 
RTOG toxicity scales, skin toxicity and mucositis. Daily MVCT 
was performed in each patient. 
Results: The median weight loss in the mid-treatment (mt) 
was 1,7 Kg, to the end of radiotherapy (ft) of 2.8 kg, to the 
first follow-up (1FU) of 3.2 kg, to the second FU (2FU) of 1.2 
kg. The evaluation of xerostomia has detected a score of 6.2 
to the mt and 5.3 to the ft, of 6.4 to the 1FU and 5.8 to the 
2FU. Dysphagia (L/S) was evaluated to the mt of 5/5, 4.7/3.7 
to the ft, 6.5/6.2 to the 1FU while 8/7.7 to the 2FU. 
Dysgeusia was 6.1 to the mt, 4.5 to the ft, 4.7 to the 1FU and 
6,1 to the 2FU. Mucositis was mild to severe G1-G3, 1 case 
has evolved into G4. Skin toxicity G1-G2. 3 patients were re-
simulate: two for loss of weight between second and the fifth 
week and the other patient at the first week for weight 
increased for concomitant use of steroids. In these cases, the 
MVCT occurred geographic miss with a hotspot on the bone 
marrow. IGRT allowed to record mismatching in 3 pts due to 
loss or increase of weight and re-simulate them. Dose 
constraints to organs at risk were easily respect in almost 
every patient due to high dose conformity allowed by HT, but 
correct contouring remains still critical. 22-24 Gy average 
planning dose was reported for parotid glands. 
Conclusions: Our experience suggest us the use of daily MVCT 
is very important in the Head & Neck cancer, to identify early 
both any changes in anatomy of patient due to an important 
weight loss, and an undersizing of the lesion in response to 
therapy, for a treatment as conformed and adapted to the 
structure of the single patient. The acute toxicity is 
acceptable. 
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Purpose/Objective: In November 2013, Radiation Oncology 
Victoria (ROV) underwent a change in its radiation therapist 
staffing model to become a smarter and more efficient 
service provider. This project was developed to assess and 
test the hypothesis that patient satisfaction and experience 
can be maintained at high levels after a change in staffing 
model, testing the belief that staffing numbers impact on 
quality of service as measured by satisfaction. By analysing 
survey data using a Net Promoter Score (NPS) methodology, 
